Cascadian Therapeutics Inc. buy stratec
Start price
30.01.18
/
50%
€5.07
Target price
13.04.18
€9.66
Performance (%)
78.29%
End price
13.04.18
€9.04
Summary
This prediction ended on 13.04.18 with a price of €9.04. With a performance of 78.29% the BUY prediction by stratec was a big success. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cascadian Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by stratec for this prediction
In the thread Cascadian Therapeutics Inc. diskutieren
Cascadian Therapeutics is a Conviction Buy
31.01.2017
- Seattle Genetics (NASDAQ:SGEN) has agreed to acquire Cascadian Therapeutics (NYSE:CASC) for $10 per share in cash, more than a 69% premium to yesterday's closing price of $5.90. Total consideration will be ~$614M.
(Vom Mitglied beendet)


